Search Results - "Pirnat, E"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Early change of thyroid hormone concentration after 131I treatment in patients with solitary toxic adenoma by Pirnat, E, Fidler, V, Zaletel, K, Gaberscek, S, Hojker, S

    Published in Nuclear medicine (2002)
    “…In spite of extensive use of 131I for treatment of hyperthyroidism, the results of early outcome are variable. In our prospective clinical study we tested…”
    Get more information
    Journal Article
  2. 2

    49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease by Bicek, Ajda, Zaletel, Katja, Gaberscek, Simona, Pirnat, Edvard, Krhin, Blaz, Gmeiner Stopar, Tanja, Hojker, Sergej

    Published in Human immunology (01-10-2009)
    “…Abstract Single nucleotide polymorphisms in the CTLA-4 gene have been suggested as genetic factors in the susceptibility to autoimmune thyroid disease (AITD)…”
    Get full text
    Journal Article
  3. 3

    The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease by Zaletel, Katja, Krhin, Blaz, Gaberscek, Simona, Pirnat, Edvard, Hojker, Sergej

    Published in Thyroid (New York, N.Y.) (01-05-2002)
    “…Increasing evidence supports the genetic susceptibility for thyroid antibody (TAb) production in patients with autoimmune thyroid disease, and recently, it has…”
    Get more information
    Journal Article
  4. 4

    Early changes of thyroid hormone concentrations after (131)I therapy in Graves' patients pretreated or not with methimazole by Pirnat, E, Zaletel, K, Gaberscek, S, Fidler, V, Hojker, S

    Published in Nuclear medicine (01-08-2004)
    “…Despite extensive use of (131)I therapy for Graves' hyperthyroidism the treatment regimen with (131)I and antithyroid drugs remain under discussion. In our…”
    Get more information
    Journal Article